VistaGen Therapeutics, Inc. - FORM 10-K - EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - June 26, 2018

Attached files

file filename
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - VistaGen Therapeutics, Inc.vtgn_ex32.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - VistaGen Therapeutics, Inc.vtgn_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - VistaGen Therapeutics, Inc.vtgn_ex311.htm
10-K - ANNUAL REPORT - VistaGen Therapeutics, Inc.vtgn_10k.htm
 
Exhibit 23.1
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-223556 and 333-208354) and Form S-3 (File No. 333-215671) of VistaGen Therapeutics, Inc. of our report dated June 26, 2018 (which report expresses an unqualified opinion and includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern), relating to the consolidated financial statements of VistaGen Therapeutics, Inc., which appears in this Annual Report on Form 10-K.
 
/s/ OUM & CO. LLP
 
San Francisco, California
June 26, 2018
 
 

VistaGen Therapeutics, Inc. Reports